KLA Corporation (K1LA34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 40.92 |
|---|---|
| 52-week range | 29.24 – 79.27 |
| Return, 1 month / 3 months | −15.9% / −21.0% |
| Return, 1 year / 3 years | +45.1% / +691.8% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 67.9% |
| Worst drawdown (1 year) | -54.1% |
| Average daily value traded | 0.94M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KLA Corporation supplies process control and yield management systems used in semiconductor manufacturing. Its equipment inspects and measures wafers, masks and packaged chips, helping chipmakers find defects and keep production on track. Customers are semiconductor and electronics manufacturers, along with related research and industrial users. The company is based in Milpitas, California, in the United States, and serves chipmaking markets around the world.
KLA Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code K1LA34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KLA Corporation (K1LA34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 40.92 on 27 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 1,109 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 45.1% and over the last three months it fell 21.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -48.3% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.0% | ||
| 6-month return | -9.0% | ||
| 12-month return, skipping the last month | 72.6% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.1% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 0.94M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −15.9% |
| 3 months | −21.0% |
| 6 months | −9.0% |
| 1 year | +45.1% |
| 3 years | +691.8% |
| 5 years | +5,302.7% |
Signals
| 50-day / 200-day average | 46.26 / 45.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.0396 |
| 14 May 2026 | USD 98.0305 |
| 11 Feb 2026 | USD 83.6745 |
| 13 Nov 2025 | USD 85.3180 |
| 14 Aug 2025 | USD 87.6840 |
| 15 May 2025 | USD 90.4875 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.